CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
This multinational, investigator-initiated, retrospective study aims to investigate outcomes
 of patients, who underwent transcatheter mitral valve implantation (TMVI), in comparison to
 those screened for TMVI but deemed ineligible, who subsequently underwent interventional
 mitral valve edge-to-edge repair, mitral valve surgery or medical/conservative therapy.
Inclusion Criteria:

 -  clinically significant mitral insufficiency

 -  patient underwent screening for TMVI

 -  echocardiography data at baseline (and after TMVI, E2E and surgery)

 -  follow-up of at least 30 days

 Exclusion Criteria:

 - age under 18 years